mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.3 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.3 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.3 |
mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.3 |